Reuters logo
BRIEF-Medigen Vaccine Biologics signs Dengue vaccine license agreement with NIH
September 18, 2017 / 6:39 AM / a month ago

BRIEF-Medigen Vaccine Biologics signs Dengue vaccine license agreement with NIH

Sept 18(Reuters) - Medigen Vaccine Biologics Corp :

* Says it signs Dengue vaccine license agreement with NIH to expand scope of authority on Sept. 17

* Says it was granted to implement R&D, manufacture, sale and sub-licensing of Dengue vaccine in 9 countries

Source text in Chinese: goo.gl/wQSZW4

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below